Plunkett Research Online: Cascadian Therapeutics Inc

CASCADIAN THERAPEUTICS INC (CASC) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cascadian Therapeutics, Inc. (formerly Oncothyreon, Inc.) is a clinical-stage biopharmaceutical company focused primarily on the development of cancer therapeutics. The company develops and commercializes novel targeted compounds that have the potential to improve the lives of cancer patients. Cas.....


CASCADIAN THERAPEUTICS INC

Ticker: CASC
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 206 801-2100
Fax: 780 463-0871
Address: 2601 Fourth Ave., Ste. 500
Seattle, WA 98121 United States

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Julie EastlandCFO/Chief Accounting Officer/Other Executive Officer/Secretary
Christopher HenneyChairman of the Board/Director
See More
Cascadian Therapeutics, Inc. (formerly Oncothyreon, Inc.) is a clinical-stage biopharmaceutical company focused primarily on the development of cancer therapeutics. The company develops and commercializes novel targeted compounds that have the potential to improve the lives of cancer patients. Cas.....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture

The company offers employees medical, dental and vision benefits; life and long-term disability insurance; a 401(k) plan; and an employee stock purchase plan.